Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: tktrimbath who wrote (382)	5/24/2003 10:15:23 AM
From: Mike McFarland	Read Replies (3) \| Respond to of 557

Stock still moving up--only burned 375k this in the quarter ended March 31st. Doing well recently compared to other gene therapy stocks perhaps, although now that I think about it, cege has moved away from GT and is focused on cancer. finance.yahoo.com Just don't click on the two and five year charts, heheh, only outperforming in the short term. ................................................ fun with lists A list of GT companies. ispex.ca www1.frost.com The following is a list of key industry participants: Advanced Therapies, Inc.; ALZA Corp.; Apoptogen, Inc.; Aradigm Corp.; ARIAD Pharmaceuticals, Inc.; Athersys, Inc.; Aventis Gencell; Avigen, Inc.; BD Biosciences Clontech; BioDelivery Sciences International, Inc.; Bio-Rad Laboratories, Inc.; BioStratum, Inc.; Biovector Therapeutics, S.A.; Canji, Inc.; Cell Gensys, Inc.; Chromos Molecular Systems, Inc.; Collateral Therapeutics, Inc.; Copernicus Therapeutics, Inc.; Dendritech, Inc.; Endocyte, Inc.; Endovasc, Ltd., Inc.; Enzo Biochem, Inc.; F.H. Faulding & Co., Ltd.; Genelabs Technologies, Inc.; Genetic Therapy, Inc.; Genetix Pharmaceuticals, Inc.; Genetronics Biomedical, Ltd.; GenStar Therapeutics Corp.; GenVec, Inc.; Genzyme Corp.; Glygen Corp.; Immune Response Corp.; Inex Pharmaceuticals, Inc.; Intronn, LLC; InvivoGen; Lexicon Genetics, Inc.; Nature Technology Corp.; Onyx Pharmaceuticals, Inc.; Polygenetics, Inc.; REPLICor, Inc.; RHeoGene, LLC; Ribozyme Pharmaceutical, Inc.; Selective Genetics, Inc.; StemCells, Inc.; StressGen Biotechnologies Corp.; Targeted Genetics Corp.; Theratechnologies, Inc.; Therion Biologics Corp.; Titan Pharmaceuticals, Inc.; Tosk, Inc.; Transkaryotic Therapies, Inc.; Valentis, Inc.; ValiGen, Inc.; and Vical, Inc. A large PDF that might be worth a look--gene therapy in Europe, a couple years old sussex.ac.uk A comprehensive list of biopharm companies researchandmarkets.com Why pointing to long lists today? I'm almost completely out of the stock market now. I wont use any of my dry powder again til something walks up and bites me on the nose.